Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study

被引：0
|
作者：
D A Reardon
A Desjardins
J J Vredenburgh
S Gururangan
J H Sampson
S Sathornsumetee
R E McLendon
J E Herndon
J E Marcello
J Norfleet
A H Friedman
D D Bigner
H S Friedman
机构：
[1] The Preston Robert Tisch Brain Tumor Center,Department of Surgery
[2] Duke University Medical Center,Department of Pediatrics
[3] The Preston Robert Tisch Brain Tumor Center,Department of Medicine
[4] Duke University Medical Center,Department of Pathology
[5] The Preston Robert Tisch Brain Tumor Center,undefined
[6] Duke University Medical Center,undefined
[7] The Preston Robert Tisch Brain Tumor Center,undefined
[8] Duke University Medical Center,undefined
[9] Cancer Center Biostatistics,undefined
[10] The Preston Robert Tisch Brain Tumor Center,undefined
[11] Duke University Medical Center,undefined
来源：
British Journal of Cancer | 2009年 / 101卷
关键词：
malignant glioma; glioblastoma; angiogenesis; bevacizumab; vascular endothelial growth factor; metronomic chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1986 / 1994
页数：8
相关论文
共 50 条
  • [41] EFFICACY OF BEVACIZUMAB PLUS IRINOTECAN IN CHILDREN WITH RECURRENT OR PROGRESSIVE MALIGNANT GLIOMA
    Arakawa, Yoshiki
    Umeda, Katsutsugu
    Watanabe, Ken-ichiro
    Mizowaki, Takashi
    Hiraoka, Masahiro
    Hiramatsu, Hidefumi
    Adachi, Souichi
    Kunieda, Takeharu
    Takagi, Yasushi
    Miyamoto, Susumu
    NEURO-ONCOLOGY, 2014, 16 : 59 - 59
  • [42] BEVACIZUMAB PLUS CARBOPLATIN INCREASES SURVIVAL IN PATIENTS WITH RECURRENT MALIGNANT GLIOMA
    Thompson, Eric M.
    Dosa, Edit
    Kraemer, Dale F.
    Neuwelt, Edward A.
    NEURO-ONCOLOGY, 2009, 11 (05) : 625 - 626
  • [43] Phase II study of topotecan in patients with recurrent malignant glioma
    Macdonald, D
    Cairncross, G
    Stewart, D
    Forsyth, P
    Sawka, C
    Wainman, N
    Eisenhauer, E
    ANNALS OF ONCOLOGY, 1996, 7 (02) : 205 - 207
  • [44] Phase II study of paclitaxel in patients with recurrent malignant glioma
    Prados, MD
    Schold, SC
    Spence, AM
    Berger, MS
    McAllister, LD
    Mehta, MP
    Gilbert, MR
    Fulton, D
    Kuhn, J
    Lamborn, K
    Rector, DJ
    Chang, SM
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (08) : 2316 - 2321
  • [45] Phase I/II trial of vorinostat, bevacizumab, and daily temozolomide for recurrent malignant gliomas
    Katherine B. Peters
    Eric S. Lipp
    Elizabeth Miller
    James E. Herndon
    Frances McSherry
    Annick Desjardins
    David A. Reardon
    Henry S. Friedman
    Journal of Neuro-Oncology, 2018, 137 : 349 - 356
  • [46] Phase I/II trial of vorinostat, bevacizumab, and daily temozolomide for recurrent malignant gliomas
    Peters, Katherine B.
    Lipp, Eric S.
    Miller, Elizabeth
    Herndon, James E., II
    McSherry, Frances
    Desjardins, Annick
    Reardon, David A.
    Friedman, Henry S.
    JOURNAL OF NEURO-ONCOLOGY, 2018, 137 (02) : 349 - 356
  • [47] Phase II Study of Bevacizumab and Vorinostat for Patients with Recurrent World Health Organization Grade 4 Malignant Glioma
    Ghiaseddin, Ashley
    Reardon, David
    Massey, Woody
    Mannerino, Alex
    Lipp, Eric S.
    Herndon, James E., II
    Mcsherry, Frances
    Desjardins, Annick
    Randazzo, Dina
    Friedman, Henry S.
    Peters, Katherine B.
    ONCOLOGIST, 2018, 23 (02): : 157 - +
  • [48] PHASE II STUDY OF ONARTUZUMAB PLUS BEVACIZUMAB VERSUS PLACEBO PLUS BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA
    Cloughesy, Tim
    Finocchiaro, Gaetano
    Belda-Iniesta, Cristobel
    Recht, Lawrence
    Brandes, Alba A.
    Pineda, Estela
    Mikkelsen, Tom
    Chinot, Olivier
    Balana, Carmen
    Macdonald, David
    Westphal, Manfred
    Hopkins, Kirsten
    Weller, Michael
    Bruey, Jean-Marie
    Liu, Bo
    Verret, Wendy
    NEURO-ONCOLOGY, 2014, 16
  • [49] METRONOMIC ANTIANGIOGENETIC BIO-CHEMOTHERAPY OF NON-SMALL CELL LUNG CANCER PATIENTS WITH FRACTIONED CISPLATIN, ORAL ETOPOSIDE AND BEVACIZUMAB: PHASE IB-II STUDY
    Correale, Pierpaolo
    Remondo, Cinzia
    Migali, Cristina
    Licchetta, Antonella
    Martellucci, Ignazio
    Carbone, Francesco
    Ricci, Veronica
    Addeo, Raffaele
    Del Prete, Salvatore
    Francini, Guido
    ANNALS OF ONCOLOGY, 2009, 20
  • [50] ORAL ETOPOSIDE IN THE TREATMENT OF MALIGNANT MESOTHELIOMA - A PHASE-II STUDY
    TAMMILEHTO, L
    MAASILTA, P
    MANTYLA, H
    SALO, J
    MATTSON, K
    ANNALS OF ONCOLOGY, 1994, 5 (10) : 949 - 950
12345